Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study

Atrial fibrillation (AF) is a common arrhythmia in patients with hypertension. ELABELA, which has cardioprotective effects, is decreased in the plasma of patients with hypertension and might be associated with AF in the hypertensive population. This study aims to measure the ELABELA plasma levels in hypertension patients with and without AF and to analyse the related factors.A total of 162 hypertension patients with or without AF were recruited...